Autor segons l'article: Alegret, JM; Viñolas, X; Arias, MA; Martínez-Rubio, A; Rebollo, P; Ràfols, C; Martínez-Sande, JL
Departament: Medicina i Cirurgia
Autor/s de la URV: Alegret Colomé, Josep Maria
Paraules clau: Warfarin Vitamin k antagonists Self-management Ribaroxaban Prevention New oral anticoagulants Impact Health-related quality of life Events Elderly-patients Dabigatran Aspirin Ablation ribaroxaban. new oral anticoagulants health-related quality of life dabigatran
Resum: New oral anticoagulants (NOAC) have demonstrated their efficacy as an alternative to vitamin K antagonists (VKA) in the prophylaxis of cardioembolic events in patients with atrial fibrillation (AF). However, evidence on the benefits of NOAC in health-related quality of life (HRQoL) is lacking. We evaluated changes in HRQoL related to oral anticoagulation therapy employing a specific questionnaire in a cohort of 416 patients with AF undergoing electrical cardioversion. In terms of HRQoL, we observed a progressive adaptation to treatment with VKA; satisfaction with NOAC remained constant. Older age, higher left ventricular ejection fraction and NOAC were associated with better HRQoL.
Àrees temàtiques: Odontología Medicine, general & internal Medicine (miscellaneous) Medicine (all) Medicina veterinaria Medicina ii Medicina i Materiais General medicine Farmacia Ensino Ciências biológicas ii Ciências biológicas i
Accès a la llicència d'ús: https://creativecommons.org/licenses/by/3.0/es/
ISSN: 14491907
Adreça de correu electrònic de l'autor: josepmaria.alegret@urv.cat
Identificador de l'autor: 0000-0002-6117-5512
Data d'alta del registre: 2024-09-07
Versió de l'article dipositat: info:eu-repo/semantics/publishedVersion
URL Document de llicència: https://repositori.urv.cat/ca/proteccio-de-dades/
Referència a l'article segons font original: International Journal Of Medical Sciences. 11 (7): 680-684
Referència de l'ítem segons les normes APA: Alegret, JM; Viñolas, X; Arias, MA; Martínez-Rubio, A; Rebollo, P; Ràfols, C; Martínez-Sande, JL (2014). New Oral Anticoagulants vs Vitamin K Antagonists: Benefits for Health-Related Quality of Life in Patients with Atrial Fibrillation. International Journal Of Medical Sciences, 11(7), 680-684. DOI: 10.7150/ijms.8916
Entitat: Universitat Rovira i Virgili
Any de publicació de la revista: 2014
Tipus de publicació: Journal Publications
Repositori URV